Bringing you the latest from Medical Developments International
Bridging the Gender Pain Gap Pain Inquiry Report 2025
Paediatric Indication For Penthrox Approved By HPRA
Medical Developments International (ASX:MVP) to support acute pain management in France through new partnership agreement with Ethypharm
Notice of Annual General Meeting 2024
Medical Developments International extends agreement for Penthrox® (Methoxyflurane) distribution with Galen in UK and Ireland.
